Tech Company Financing Transactions
LPOXY Therapeutics Funding Round
LPOXY Therapeutics, based in Platte City, secured $28 million from 5 Horizons Capital.
Transaction Overview
Company Name
Announced On
9/3/2025
Transaction Type
Venture Equity
Amount
$28,000,000
Round
Series A
Investors
5 Horizons Capital (Lead Investor)
Proceeds Purpose
The company intends to use the funds to accelerate its registrational STOP-Cdiff (SIDIPREV� Trial On Prevention of C. difficile Infections) clinical trial.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Platte City, MO Undisclosed
USA
Platte City, MO Undisclosed
USA
Phone
Website
Email Address
Not Recorded
Overview
The LPOXY team is driven to protect people from this deadly antibiotic-induced superinfection. LPOXY Therapeutics is developing a pill that taken with antibiotics gently increases the colon's oxygen tension to prevent antibiotic-induced C. difficile colitis via multiple mechanisms.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Larry Sutton
Browse more venture capital transactions:
Prev: 9/3/2025: Offgrid Energy Labs venture capital transaction
Next: 9/3/2025: XIFIN venture capital transaction
Share this article
About Our VC Transactions Data
We record every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs